India hoping to break China’s grip on industry


Big dreams: The Novartis research and development centre under construction at Genome Valley in Hyderabad. Modi is eagerly promoting his country as the pharmacy of the world as it aims to become a top supplier of drug ingredients. — Bloomberg

NEW DELHI: On the edge of Hyderabad in southern India, a vast patch of arid shrub-land the size of about 14,000 football fields is becoming a testing ground for a model that could help wean the world off its dependence on Chinese drug ingredients.

This empty site of the Hyderabad Pharma City, marked out by scuffed sign posts and a rubble-strewn access road is expected to attract about US$8.4bil (RM36bil) and employ 560,000 people in hundreds of sprawling plants.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Chinese drug ingredients ,

   

Next In Business News

OCK proposed RM500mil ICP programme
Profit-taking in the market, KLCI down 0.14%
EPF balancing between retirement mandate and supporting members' economic survival
Asian stocks hit by US tech slide, FX subdued
CelcomDigi emphasises its significant role in protecting customers from AI-related risks
China's largest auto show showcases all-electric future, local brands dominate
Unilever beats first quarter sales forecasts, sticks to 2024 outlook
Oil steady as market weighs US demand concerns, Middle East conflict risks
HeiTech Padu targets stronger earnings growth after returning to black in 2023
PBOC may up bond trading

Others Also Read